Low Meningococcal Vaccination Rates among Patients with Newly Diagnosed Complement Component Deficiencies in the United States.

Gary S. Marshall,Parinaz K. Ghaswalla,Lindsay G. S. Bengtson,Ami R. Buikema,Tim Bancroft,Eleena Koep,Patricia Novy,Cosmina S. Hogea

Clinical infectious diseases/Clinical infectious diseases (Online University of Chicago Press)（2021）

引用 3|浏览14

暂无评分

摘要

Meningococcal vaccination is recommended for patients with complement component deficiencies (CDs) in the United States. In this retrospective database study, only 4.6% and 2.2% of patients received MenACWY and MenB vaccination, respectively, within 3 years of CD diagnosis. Thus, meningococcal vaccination rates among patients with CDs need to be improved.

查看译文

关键词

meningococcal vaccine,complement component deficiencies,meningococcal serogroups A,and Y (MenACWY),meningococcal serogroup B (MenB)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要